Navigation Links
Clarient Reports Second Quarter Revenue Up 40 Percent
Date:8/4/2009

s business model built on a balanced revenue stream across multiple cancer types and technologies is well positioned in the new environment of health reform and cost containment. The opportunities for Clarient to use its established commercial engine to bring new advanced tests to market are numerous and growing daily, and we are hard at work identifying which of those opportunities we will pursue while maintaining a focus on profitability."

Conference Call

Clarient will hold a conference call to discuss second quarter 2009 results. The call will include a period for questions and answers.

    Date:  Tuesday, August 4, 2009
    Time:  5:00 p.m. Eastern
    Call-in Number: 1-877-941-6012 (domestic)  +480-629-9771 (international)
    Conference ID Number: 4121615
    Webcast: www.clarientinc.com/investor
    Web Replay:  For those unable to participate during the live broadcast,
    the webcast replay will be archived at www.clarientinc.com/investor
    shortly after the call and will be available for one year.

About Clarient

Clarient combines innovative diagnostic technologies with world class pathology expertise to assess and characterize cancer. Clarient's mission is to become the leader in cancer diagnostics by dedicating itself to collaborative relationships with the healthcare community to translate cancer discovery and research into better patient care. The Company's principal customers include pathologists, oncologists, hospitals and biopharmaceutical companies. The rise of individualized medicine as the new direction in oncology has created the need for a centralized resource providing leading diagnostic technologies, such as flow cytometry and molecular testing. Clarient is that resource, having created a state-of-the-art commercial cancer laboratory providing the most advanced oncology testing and diagnostic services available both onsite and
'/>"/>

SOURCE Clarient, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Clarient to Present at the UBS 2007 Global Life Sciences Conference
2. Clarient Names Michael J. Pellini, M.D. Chief Operating Officer
3. Clarient Names Michele Hibbard, Ph.D. Director of Genetics
4. Clarient Generates 52% Revenue Increase in Third Quarter 2007
5. Clarient Named to Deloittes 2007 Orange County Technology Fast 50 for Third Consecutive Year
6. Clarient CEO Andrews to Participate in Panel Discussion at the RBC Capital Markets 2007 Healthcare Conference
7. Clarient to Present at the B. Riley & Co. 9th Annual Las Vegas Investor Conference
8. Clarient Reports First Quarter 2008
9. Clarient Partners With Joint Venture Hospital Laboratories to Offer Pathologists Wide Array of Cancer Assays
10. Clarient Renews and Expands Mezzanine Credit Facility With Safeguard
11. Clarient Reschedules Fourth Quarter and Year-End 2008 Financial Results Release To Wednesday, March 11th; Conference Call and Webcast Rescheduled For 5:00 PM EDT That Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... The 2015 ... to patients and family members, medical professionals, and researchers, covering a variety of ... conference is a collaborative effort between the Mesothelioma Applied Research Foundation ...
(Date:8/31/2015)... CA (PRWEB) , ... August 31, 2015 , ... Patients ... from and those who are interested in learning more about the procedure beyond the ... Mohebi. , Internationally recognized hair transplant surgeon Parsa Mohebi will be on hand ...
(Date:8/31/2015)... , ... August 31, 2015 , ... The Sundance Film ... on Tuesday, September 1. , “Alive Inside” shadows a social worker who advocates for ... , “It’s a documentary about bringing music to residents in health care centers who ...
(Date:8/31/2015)... Scotch Plains, NJ (PRWEB) , ... August 31, ... ... in practice! Garden State Urology was formed in 2008, the result of a ... on the principle that by working cooperatively, they could provide more cost-effective and ...
(Date:8/31/2015)... ... ... Docs Presents, Dr. Michael Betsy! Dr. Betsy has been reviewed and approved as an ... from Don Bosco Prep in 1990 and was Class Salutatorian. He earned Varsity letters ... senior year. He was inducted into the National Honor Society as a sophomore, was ...
Breaking Medicine News(10 mins):Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:Watch a Live Hair Transplant at Parsa Mohebi Hair Restoration’s Open House 2Health News:Public Invited to Dementia Documentary Screening at North Carolina Retirement Community 2Health News:NJ Top Docs Presents, Garden State Urology! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3
... , FRIDAY, Sept. 23 (HealthDay News) -- Many people who ... or when they come out, and a new study may ... used during an MRI pushes on fluid circulating in the ... of vertigo or free-falling. , , In the study, published ...
... , FRIDAY, Sept. 23 (HealthDay News) -- Fred Wyand has ... the public health response to human papillomavirus, or HPV. ... News , a bimonthly newsletter published by the American Social ... HPV is a sexually transmitted disease that most people ...
... THURSDAY, Sept. 22 (HealthDay News) -- A new study finds ... leukemia than whites. But if they do become ill, they,re ... reason for the disparity, but now that we know it ... researcher Dr. Manali I. Patel, postdoctoral fellow in hematology/oncology at ...
... Utah biochemist Brenda L. Bass, Ph.D., has dedicated her ... That bent hasn,t come without risks for the ... who researches double-stranded RNA (dsRNA), an elusive molecule whose ... has made substantial discoveries involving dsRNA in the past ...
... THURSDAY, Sept. 22 (HealthDay News) -- Almost 7 percent of men ... within 30 days of the procedure, a new study indicates. ... do not get prostate biopsies can expect to be hospitalized, according ... of Urology . "The overall hospitalization rate is about twice ...
... using an automatic speech recognition system are nearly six ... generated with conventional dictation transcription, a new study in ... complex cases discussed on multidisciplinary team rounds: 308 ... the report and software immediately transcribes the report on ...
Cached Medicine News:Health News:Magnetic Field May Cause MRI-Induced Vertigo 2Health News:Stress the 'Human' in HPV, One Man Suggests 2Health News:Stress the 'Human' in HPV, One Man Suggests 3Health News:Death Rate Higher in Minorities With Acute Leukemia 2Health News:Utah biochemist Brenda L. Bass wins NIH Pioneer Award 2Health News:Utah biochemist Brenda L. Bass wins NIH Pioneer Award 3Health News:Utah biochemist Brenda L. Bass wins NIH Pioneer Award 4Health News:In Older Men, Prostate Biopsies Can Raise Risk of Hospitalization 2Health News:In Older Men, Prostate Biopsies Can Raise Risk of Hospitalization 3Health News:Error rate higher in breast imaging reports generated by automatic speech recognition 2
(Date:8/31/2015)... 31, 2015 Pepperl+Fuchs, a world leader ... Corporation, a leading provider of HART protocol devices. ... further extend its integrated solutions offerings and strengthen ... "We are pleased to add the MACTek ... Jim Bolin , Pepperl+Fuchs, executive vice president ...
(Date:8/31/2015)... , Aug. 31, 2015  Ascendant Solutions, Inc. ... today announced that its Healthcare subsidiary, Dougherty,s Holdings, has ... on the downtown square of Springtown, Texas ... than 35 years, this community-based pharmacy has provided retail ... of Springtown . The ...
(Date:8/31/2015)... 2015  Daktari Diagnostics today announced a collaboration with Merck, ... and Canada , to develop Daktari,s ... up to $8.5 million over the next 3.5 years, will ... regulatory approval of Daktari,s HCV test. The ... can detect low levels of virus directly in a single ...
Breaking Medicine Technology:Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 2Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 3Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 2Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 3
... grounds, direct programming is superior,to cloning as a ... Nov. 20 Two major scientific,papers published this ... way to,generate patient-matched human pluripotent stem cells without ... or human or animal eggs.,Research groups in Wisconsin ...
... 20 The following statement,was released today by ... the Elizabeth Glaser Pediatric AIDS Foundation:, "Four ... Relief,(PEPFAR) began funding treatment and prevention, today,s report ... remains a devastating worldwide,pandemic, we are beginning to ...
Cached Medicine Technology:Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo 2Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo 3New UNAIDS Report Offers Encouraging News, But Most HIV-Positive Mothers Still Not Getting the Care & Treatment They Need 2
Alcon offers medical grade perfluoropropane (C3F8) intraocular gases for ophthalmological use....
Round knurled handle. Overall length 130 mm....
Optimum C/D/S Solution is a sterile cleaning, disinfecting, and storage solution for use with fluorosilicone acrylate and silicone acrylate rigid gas permeable (RGP) and hard contact lenses....
5 inch (12.7 cm), 2 x 5 mm blade....
Medicine Products: